Literature DB >> 14982754

Combination antifungal therapy.

Melissa D Johnson1, Conan MacDougall, Luis Ostrosky-Zeichner, John R Perfect, John H Rex.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 14982754      PMCID： PMC353116          DOI： 10.1128/AAC.48.3.693-715.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  218 in total

Review 1.  Rational approach to the clinical protocol design for drug combinations: a review.

Authors:  T T Chang; T C Chou
Journal:  Acta Paediatr Taiwan       Date:  2000 Nov-Dec

2.  Experimental application of the median-effect principle for in vitro quantification of the combined inhibitory activities of clavulanic acid and imipenem against IRT-4 beta-lactamase.

Authors:  Albert Sotto; Vincent Foulongne; Danielle Sirot; Roger Labia; Jacques Jourdan
Journal:  Int J Antimicrob Agents       Date:  2002-01       Impact factor: 5.283

3.  Combination therapy with caspofungin and amphotericin B lipid complex.

Authors:  Linda R Lum; Thomas F Turco; John Leone
Journal:  Am J Health Syst Pharm       Date:  2002-01-01       Impact factor: 2.637

4.  Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.

Authors:  A Louie; P Kaw; P Banerjee; W Liu; G Chen; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

5.  Identification of rare Candida species and other yeasts by polymerase chain reaction and slot blot hybridization.

Authors:  J Loeffler; H Hebart; S Magga; D Schmidt; L Klingspor; J Tollemar; U Schumacher; H Einsele
Journal:  Diagn Microbiol Infect Dis       Date:  2000-12       Impact factor: 2.803

Review 6.  Antifungal pharmacodynamics: review of the literature and clinical applications.

Authors:  E S Dodds; R H Drew; J R Perfect
Journal:  Pharmacotherapy       Date:  2000-11       Impact factor: 4.705

7.  In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates.

Authors:  S Arikan; M Lozano-Chiu; V Paetznick; J H Rex
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

8.  Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia.

Authors:  H Hebart; J Löffler; H Reitze; A Engel; U Schumacher; T Klingebiel; P Bader; A Böhme; H Martin; D Bunjes; W V Kern; L Kanz; H Einsele
Journal:  Br J Haematol       Date:  2000-11       Impact factor: 6.998

9.  In-vitro synergistic effect of fluconazole with nonsteroidal anti-inflammatory agents against Candida albicans strains.

Authors:  M Yücesoy; I M Oktem; Z Gülay
Journal:  J Chemother       Date:  2000-10       Impact factor: 1.714

10.  Candida lusitaniae: a cause of breakthrough fungemia in cancer patients.

Authors:  A Minari; R Hachem; I Raad
Journal:  Clin Infect Dis       Date:  2000-12-28       Impact factor: 9.079
View more
  150 in total

1.  In vitro and in vivo trypanocidal synergistic activity of N-butyl-1-(4-dimethylamino)phenyl-1,2,3,4-tetrahydro-β-carboline-3-carboxamide associated with benznidazole.

Authors:  Rodrigo Hinojosa Valdez; Lilian Tatiani Düsman Tonin; Tânia Ueda-Nakamura; Sueli Oliveira Silva; Benedito Prado Dias Filho; Edilson Nobuyoshi Kaneshima; Sueli Fumie Yamada-Ogatta; Lucy Megumi Yamauchi; Maria Helena Sarragiotto; Celso Vataru Nakamura
Journal:  Antimicrob Agents Chemother       Date:  2011-10-28       Impact factor: 5.191

2.  Posaconazole enhances the activity of amphotericin B against Aspergillus hyphae in vitro.

Authors:  Susanne Perkhofer; Helene Lugger; Manfred P Dierich; Cornelia Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

3.  Differences in interactions between azole drugs related to modifications in the 14-alpha sterol demethylase gene (cyp51A) of Aspergillus fumigatus.

Authors:  G Garcia-Effron; E Mellado; A Gomez-Lopez; L Alcazar-Fuoli; M Cuenca-Estrella; Juan L Rodriguez-Tudela
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

4.  In vitro and in vivo interactions between miltefosine and other antileishmanial drugs.

Authors:  Karin Seifert; Simon L Croft
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

5.  In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata.

Authors:  E R Oliveira; A W Fothergill; W R Kirkpatrick; B J Coco; T F Patterson; S W Redding
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  Discovery of compounds blocking the proliferation of Toxoplasma gondii and Plasmodium falciparum in a chemical space based on piperidinyl-benzimidazolone analogs.

Authors:  Nadia Saïdani; Cyrille Y Botté; Michael Deligny; Anne-Laure Bonneau; Janette Reader; Ronald Lasselin; Goulven Merer; Alisson Niepceron; Fabien Brossier; Jean-Christophe Cintrat; Bernard Rousseau; Lyn-Marie Birkholtz; Marie-France Cesbron-Delauw; Jean-François Dubremetz; Corinne Mercier; Henri Vial; Roman Lopez; Eric Maréchal
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

7.  Posaconazole enhances the activity of amphotericin B against hyphae of zygomycetes in vitro.

Authors:  Susanne Perkhofer; Maria Locher; Manuel Cuenca-Estrella; Reinhard Rüchel; Reinhard Würzner; Manfred P Dierich; Cornelia Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

8.  Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time bioluminescence imaging.

Authors:  Célimène Galiger; Matthias Brock; Grégory Jouvion; Amélie Savers; Marianna Parlato; Oumaïma Ibrahim-Granet
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

9.  Effect of farnesol on growth, ergosterol biosynthesis, and cell permeability in Coccidioides posadasii.

Authors:  Raimunda Sâmia Nogueira Brilhante; Rita Amanda Chaves de Lima; Erica Pacheco Caetano; João Jaime Giffoni Leite; Débora de Souza Collares Maia Castelo-Branco; Joyce Fonteles Ribeiro; Tereza de Jesus Pinheiro Gomes Bandeira; Rossana de Aguiar Cordeiro; André Jalles Monteiro; José Júlio Costa Sidrim; Marcos Fábio Gadelha Rocha
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

Review 10.  Invasive candidiasis in pediatric intensive care units.

Authors:  Sunit Singhi; Akash Deep
Journal:  Indian J Pediatr       Date:  2009-11-12       Impact factor: 1.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.